Skip to main content
. 2021 Oct 23;10(11):1371. doi: 10.3390/pathogens10111371

Table 1.

Comparative antimicrobial activities of tested agents in vitro, against four most common species of yeast isolated from damaged voice prostheses.

Agent MIC (µg/mL) MFC (µg/mL) MBIC (µg/mL)
Range 50% 90% Range 50% 90% Range 50% 90%
Candida albicans (n = 14)
Amphotericin B 0.5–512 0.5 1 0.5–512 0.5 1 0.5–512 1 32
Fluconazole 0.5–512 16 512 1–512 128 512 2–512 128 512
Omiganan 32–512 128 256 64–512 128 256 64–512 128 256
LL-37 16–512 512 512 64–512 512 512 64–512 512 512
CSA-13 0.5–8 2 8 1–8 4 8 2–16 4 8
CSA-131 0.5–2 0.5 2 0.5–2 0.5 2 0.5–2 1 2
CSA-44 1–8 4 8 1–8 4 8 1–8 4 8
CSA-138 0.5–4 1 4 0.5–4 1 4 0.5–8 1 4
Candida krusei (n = 15) *
Amphotericin B 0.5–128 1 4 0.5–256 2 8 0.5–256 2 4
Omiganan 16–256 64 128 32–512 64 128 32–256 128 256
LL-37 16–512 512 512 16–512 512 512 16–512 512 512
CSA-13 0.5–2 2 2 0.5–2 2 2 0.5–8 2 4
CSA-131 0.5 0.5 0.5 0.5 0.5 0.5 0.5–1 0.5 1
CSA-44 0.5–4 1 2 0.5–4 1 2 0.5–4 1 4
CSA-138 0.5–4 0.5 1 0.5–4 0.5 2 0.5–4 1 2
Candida tropicalis (n = 12)
Amphotericin B 0.5–8 1 4 0.5–16 2 8 0.5–16 2 4
Fluconazole 1–512 2 32 2–512 4 128 2–512 4 128
Omiganan 16–128 32 128 16–256 64 128 32–256 64 128
LL-37 128–512 512 512 128–512 512 512 512 512 512
CSA-13 0.5–2 1 2 0.5–4 1 4 0.5–4 1 4
CSA-131 0.5–1 0.5 1 0.5–1 0.5 1 0.5–2 0.5 1
CSA-44 0.5–2 1 2 0.5–4 1 2 1–2 1 2
CSA-138 0.5–4 0.5 2 0.5–4 1 2 0.5–4 1 2
Candida glabrata (n = 13)
Amphotericin B 0.5–16 1 4 0.5–16 2 4 0.5–128 2 16
Fluconazole 2–512 128 512 4–512 256 512 4–512 512 512
Omiganan 16–512 256 512 32–512 256 512 64–512 256 512
LL-37 16–512 512 512 64–512 512 512 64–512 512 512
CSA-13 0.5–4 2 4 0.5–4 2 4 0.5–8 2 4
CSA-131 0.5–1 0.5 0.5 0.5–1 0.5 0.5 0.5–4 1 2
CSA-44 0.5–4 1 4 0.5–4 2 4 1–8 2 4
CSA-138 0.5–4 1 4 0.5–4 1 4 0.5–4 1 4

* Candida krusei exhibits natural resistance to fluconazole. MIC/MFC/MBIC values have not been determined.